EFG
ABBV icon

Ethos Financial Group’s AbbVie ABBV Stock Holding History

Ethos Financial Group’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.99M Buy
11,698
+664
+6% +$143K 0.2% 104
2026
Q1 		$2.49M Buy
11,034
+183
+2% +$40.6K 0.18% 120
2025
Q4 		$2.48M Sell
10,851
-593
-5% -$135K 0.18% 118
2025
Q3 		$2.65M Sell
11,444
-249
-2% -$50.7K 0.21% 103
2025
Q2 		$2.17M Buy
11,693
+387
+3% +$71.9K 0.19% 115
2025
Q1 		$2.28M Buy
11,306
+8,555
+311% +$1.66M 0.22% 107
2024
Q4 		$489K Sell
2,751
-215
-7% -$39.5K 0.06% 157
2024
Q3 		$586K Buy
2,966
+54
+2% +$10.1K 0.1% 118
2024
Q2 		$513K Buy
2,912
+525
+22% +$87K 0.09% 128
2024
Q1 		$435K Sell
2,387
-300
-11% -$51.7K 0.08% 157
2023
Q4 		$416K Sell
2,687
-880
-25% -$128K 0.09% 159
2023
Q3 		$532K Buy
3,567
+197
+6% +$28.9K 0.14% 90
2023
Q2 		$537K Hold
3,370
– – 0.18% 68
2023
Q1 		$537K Sell
3,370
-875
-21% -$134K 0.17% 78
2022
Q4 		$687K Buy
+4,245
New +$651K 0.23% 61

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Ethos Financial Group's ABBV Position: Q2 2026 in Review

Ethos Financial Group increased its AbbVie (ABBV) stake by 6% in Q2 2026, buying an estimated $143K and bringing the position to 11,698 shares worth $2.99M. The position accounts for 0.2% of the portfolio, ranked #104.

Ethos Financial Group first reported a position in ABBV in Q4 2022 and has held it in 15 quarters since. 4,195 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Ethos Financial Group held 11,698 shares of AbbVie worth $2.99M as of Q2 2026.
  • Ethos Financial Group bought 664 AbbVie shares in Q2 2026, an estimated $143K.
  • AbbVie made up 0.2% of Ethos Financial Group's portfolio in Q2 2026, its #104 holding.
  • Ethos Financial Group first reported a position in AbbVie in Q4 2022 and has held it in 15 quarters since.
  • 4,195 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Ethos Financial Group's 13F filing for Q2 2026, filed 7 Aug 2026.